Product Information
AZILECT 1 MG TABLET is a brand product labeled by Teva Neuroscience, Inc., priced at $44.0804 per EA under NDC 68546022956. Its NADAC has been published 642 times since Nov 28, 2013.
FDA first approved this application on May 16, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Teva Neuroscience, Inc.NDC
68546022956
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
1/1/2026
Active Ingredients
RASAGILINE MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA021641FDA Approved
5/16/2006
TE Code
AB
On Market Since
7/10/2006
Pharmacological Classes
Price Statistics
The NADAC for AZILECT 1 MG TABLET has been published 642 times since Nov 28, 2013, and over the history we have for it it has risen 210.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $44.0804 per EA |
|---|---|
| All-time high | $44.0804 (Mar 11, 2026) |
| All-time low | $14.2108 (Nov 28, 2013) |
| 52-week high | $44.0804 |
| 52-week low | $40.2929 |
| Median price | $26.7768 |
| Average price | $26.9419 |
| Largest weekly change | +9.9% (Jan 7, 2015) |
| Weeks tracked | 642 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
+9.4%
3Y
+31.1%
5Y
+50.5%
All
+210.2%
Last surveyed Mar 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AZILECT 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AZILECT 1 MG TABLET, manufactured by Teva Neuroscience, Inc., is $44.0804 per EA (NDC 68546022956), effective Mar 11, 2026.
How has the price of AZILECT 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for AZILECT 1 MG TABLET has risen 210.2%. It has been tracked across 642 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AZILECT 1 MG TABLET?
Since Nov 28, 2013, the NADAC for AZILECT 1 MG TABLET has ranged from a low of $14.2108 (Nov 28, 2013) to a high of $44.0804 (Mar 11, 2026), with a median of $26.7768 per EA.
Are there cheaper alternatives to AZILECT 1 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RASAGILINE MESYLATE 1 MG TAB, is $1.0319 per EA — about 98% below AZILECT 1 MG TABLET.
Who manufactures AZILECT 1 MG TABLET?
AZILECT 1 MG TABLET (NDC 68546022956) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.